Systems Oncology
Business Services · Arizona, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
7201 E Henkel Way Ste 205, Scottsdale, A...Phone Number
(480) 422-2320Website
www.systemsoncology.comRevenue
<$5 MillionIndustry
About Systems Oncology
Systems Oncology specializes in translating big data into innovative cancer therapies through advanced cognitive computing technologies. Their unique approach involves aggregating and analyzing diverse biomedical datasets to identify therapeutic vulnerabilities in cancer, which they then exploit in collaboration with leading universities and pharmaceutical companies. The company aims to accelerate cancer drug development by investing in promising experimental agents and demonstrating their therapeutic potential. Their intended clients include pharmaceutical companies seeking to partner in the development of breakthrough cancer therapies.Explore more
Systems Oncology Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Systems Oncology
Compare insights from companies similar to Systems Oncology, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Systems Oncology Tech Stack
A closer look at the technologies used by Systems Oncology
See more technologies
Top Business Services Companies
Top companies in Australia by revenue
Frequently Asked Questions Regarding Systems Oncology
Sign Up For FreeTo access detailed company insights
Systems Oncology specializes in translating big data into innovative cancer therapies through advanced cognitive computing technologies. Their unique approach involves aggregating and analyzing diverse biomedical datasets to identify therapeutic vulnerabilities in cancer, which they then exploit in collaboration with leading universities and pharma... Read More
